Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: Atlas Venture Fund X, L.P. May 28, 2026 04:29PM
Q32 Bio shares up 26% on $55 million financing round May 27, 2026 08:41AM
Q32 Bio raises $55 million in private placement financing May 27, 2026 08:00AM
Form 13F-HR Atlas Venture Life Scien For: Mar 31 May 14, 2026 04:30PM
Form SCHEDULE 13G/A Generation Bio Co. Filed by: Atlas Venture Fund X, L.P. May 14, 2026 04:25PM
View Older Stories

May 14, 2026 04:21PM Form SCHEDULE 13G/A Day One Biopharmaceutica Filed by: Atlas Venture Fund XI, L.P.
May 6, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 6, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 6, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 6, 2026 04:42PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 5, 2026 04:39PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 5, 2026 04:37PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 5, 2026 04:37PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 5, 2026 04:37PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 4, 2026 05:01PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 4, 2026 05:00PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 4, 2026 04:59PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 4, 2026 04:59PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 1, 2026 10:29AM Form 13F-HR Atlas Venture Advisors, For: Mar 31
May 1, 2026 10:26AM Form 13F-NT Atlas Venture Associates For: Mar 31
May 1, 2026 10:25AM Form 13F-NT Atlas Venture Associates For: Mar 31
May 1, 2026 10:22AM Form 13F-NT Atlas Venture Fund VIII, For: Mar 31
Apr 28, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 28, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 28, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 28, 2026 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 27, 2026 04:50PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 27, 2026 04:49PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 27, 2026 04:49PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 27, 2026 04:48PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 24, 2026 04:47PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 24, 2026 04:47PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 24, 2026 04:46PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 24, 2026 04:46PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 23, 2026 06:56PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 22, 2026 04:54PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 22, 2026 04:54PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 22, 2026 04:53PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 22, 2026 04:53PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 22, 2026 04:52PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Apr 22, 2026 04:52PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 21, 2026 04:54PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 21, 2026 04:54PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 21, 2026 04:53PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 21, 2026 04:53PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Apr 20, 2026 04:44PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
Apr 15, 2026 04:52PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Apr 15, 2026 04:51PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Apr 14, 2026 02:08PM Galera and Obsidian merge in $350 million all-stock deal
View Older Stories